RxDoctor Payments DataLook up a doctor →

Samuel Wellman, MD

Orthopaedic Surgery · Durham, NCNPI 1992836837

Payments from drug & device makers

$1,258,973in general payments, 2019–2025

Across 449 payments — averaging $2803.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$713K
  • Smith+Nephew$258K
  • Stryker$186K
  • Total Joint Orthopedics, Inc.$54K
  • Medical Device Business Services, Inc.$24K
  • Medacta USA, Inc.$21K
  • plus $3K from 9 others
$159,129in research payments, 2019–2025

Across 21 payments — averaging $7577.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medacta USA, Inc.$155K
  • Zimmer Biomet$5K

What the payments were for

  • Royalty or licence$4,9463%
  • Consulting fees$76,03847%
  • Speaking & faculty fees$2,5002%
  • Travel & lodging$8,2685%
  • Food & beverage$7,4145%
  • Education$62,31539%
  • Gifts$2370%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,258,973 in reported general payments places this provider in the 95th percentile of 845 orthopaedic surgery providers in North Carolina.

See all orthopaedic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$262,284
Medicare patients
389
Services billed
803

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone27$147
Meloxicam70$117
Gabapentin12$59
Amoxicillin14$14

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →